Mice homozygous for the gene lpr develop marked lymphadenopathy and a spectrum of autoantibodies closely resembling that of human systemic lupus erythematosus. The unusual T cell phenotype of the expanded lymphocyte population and the T-dependence of several antibodies in this strain have suggested that primary T cell abnormalities underlie the autoimmune syndrome. Using double chimeras, we now show that expression of the lpr gene in B cells is absolutely necessary for autoantibody production. Combinations of antiThy 1 .2 + C' treated bone marrow from congenic strains of C57BL/6 mice, differing only at the immunoglobulin heavy chain (Igh) and lpr loci, were transferred into lethally irradiated B6/lpr mice . Double chimerism was documented by allotype-specific surface IgD and IgM immunofluorescence assay of peripheral blood and by allotype-specific enzyme-linked immunosorbent assay for total IgM in serum. Despite the presence of both +/+ and lpr B cells, IgM and IgG2a anti-chromatin as well as IgM anti-IgG were entirely the products of lpr B cells. Total serum IgG2a and IgG1 were also dominated by the 1pr phenotype but not to the same extent. A similar experiment using B6/lpr-Igh' recipients confirmed these findings . Additional experiments in which B6/lpr recipients were infused with ratios of donor bone marrow favoring B6 .C20 +/+ over B6/lpr showed that even though +/+ B cells were overrepresented, autoantibodies were only of the lpr allotype . In addition, in the presence of lpr B cells, normal B cells showed little response to an exogenous, T cell-dependent antigen. The data thus indicate that 1pr B cells manifest an intrinsic abnormality which is essential for autoantibody production in the lpr model.
Mice homozygous for the gene lpr develop marked lymphadenopathy and a spectrum of autoantibodies closely resembling that of human systemic lupus erythematosus. The unusual T cell phenotype of the expanded lymphocyte population and the T-dependence of several antibodies in this strain have suggested that primary T cell abnormalities underlie the autoimmune syndrome. Using double chimeras, we now show that expression of the lpr gene in B cells is absolutely necessary for autoantibody production. Combinations of antiThy 1 .2 + C' treated bone marrow from congenic strains of C57BL/6 mice, differing only at the immunoglobulin heavy chain (Igh) and lpr loci, were transferred into lethally irradiated B6/lpr mice . Double chimerism was documented by allotype-specific surface IgD and IgM immunofluorescence assay of peripheral blood and by allotype-specific enzyme-linked immunosorbent assay for total IgM in serum. Despite the presence of both +/+ and lpr B cells, IgM and IgG2a anti-chromatin as well as IgM anti-IgG were entirely the products of lpr B cells. Total serum IgG2a and IgG1 were also dominated by the 1pr phenotype but not to the same extent. A similar experiment using B6/lpr-Igh' recipients confirmed these findings . Additional experiments in which B6/lpr recipients were infused with ratios of donor bone marrow favoring B6 .C20 +/+ over B6/lpr showed that even though +/+ B cells were overrepresented, autoantibodies were only of the lpr allotype . In addition, in the presence of lpr B cells, normal B cells showed little response to an exogenous, T cell-dependent antigen. The data thus indicate that 1pr B cells manifest an intrinsic abnormality which is essential for autoantibody production in the lpr model. M ice homozygous for the autosomal recessive gene lpr develop a broad spectrum of autoantibodies and a clinical syndrome resembling human SLE . One of the most striking features of these mice is the marked accumulation of abnormal lymphocytes in lymph nodes and, to a lesser extent, in the spleen . The expanded population appears to be of T cell lineage, since the cells bear T cell receptors (1, 2) and have a germline immunoglobulin gene configuration (2) . However, most are of an atypical phenotype, positive for Thy 1 but negative for CD4 and CD8 (3, 4) . These "double negative" T cells (DNTs)1 also bear unusual markers, such as Ly-6 (5), Ly24 (6), PCA (7), and H1.2F3 (8) . Despite their 1 Abbreviations used in this paper. BBS, borate buffered saline; BMC, bone marrow cell ; B6, C57BL/6Byj; B6/lpr, C57BL/6-Ipr/lpr; B6/lpr-Igh=, C57BL/6-lpr/lpr-Iglw/Igip ; DEA, diethanolamine; DNT, double negative T cell; DTT, dithiothreitol; EDP, equivalent dilution factor; Igh, immunoglobulin heavy chain; MB/lpr, (MRL/lpr x B6/lpr)FI ; MRL/Ipr, MRL/Mp-lpr/lpr; MRL/+, MRL/Mp-+ / + ; PNP, paranitrophenyl phosphate ; SS, single-stranded; TNP-HSA, trinitrophenyl-human serum albumin . massively expanded numbers in vivo, these cells have been surprisingly inert in vitro (9, 10) .
Since the T cells in lpr mice seem so obviously deranged, this population has been the primary focus of a large body of research (11) . In vivo treatment with anti-T cell mAb (12) or neonatal thymectomy (13-15) greatly diminished adenopathy and autoantibody production, while thymectomy followed by transplantation of a normal thymus reconstituted disease (16). More recently, we have demonstrated that the characteristically abnormal T cells in lpr mice are intrinsically defective (17). Lethally irradiated C57BL/6-lpr/lpr (B6/lpr) mice reconstituted with equal amounts of bone marrow from normal congenic mice (C57BL/6-Ly1 .1) and from B6/lpr (Ly 1 .2') mice developed massive lymphadenopathy as well as autoantibodies comparable in titer to mice reconstituted with B6/lpr marrow alone. Strikingly, the lymphadenopathy was due almost entirely to cells derived from the 1pr marrow, indicating that normal T cells were not undergoing abnormal differentiation in an lpr environment .
B cells from IF mice, in contrast, are not as obviously ab-normal ; yet certain defects have been identified . B cells from older lpr mice hyperexpress Ia (18), but otherwise have no known aberrant markers. Polyclonal activation at an early age has been demonstrated (19) , and B cell tolerance can be difficult to induce (20, 21) . The C57BL/6-nu/nu,lpr/lpr strain develops some autoantibodies in the absence of functional T cells (22) , suggesting that the lpr B cell is intrinsically abnormal . AntiIgM treatment of B6/lpr mice depleted B cells, as expected, but more interestingly, resulted in a moderate reduction in adenopathy (23, 24) and a marked decrease in glomerulitis (23) . Recently, Perkins et al . (25) have shown that neonatal MRIrMp-+/+ (MRL/+) mice engrafted with allotypecongenic MRL/Mp-lpr/lpr-Igh°bone marrow preferentially developed total IgG2a and IgG2a anti-single stranded (ss)DNA antibodies of donor lpr allotype . This occurred despite indirect evidence that most of the splenic B cells were of host origin .
In the present work, we have tested critically whether autoantibody production in the Ipr model of SLE depends on lpr-determined B cell abnormalities. Using congenic strains on the B6 background, we have created double chimeras so that normal and lpr B cells, marked by allotype, could develop together in an lpr environment. Although the resultant mice contained large numbers of both normal and lpr B cells, they produced IgM and IgG2a autoantibodies almost exclusively o£ the lpr donor allotype. Therefore, lpr B cells are intrinsically prone to produce autoantibodies and are not merely passive recipients of abnormal signals from aberrant lpr T cells. Furthermore, the striking autoantibody production of the Ipr mouse absolutely requires this intrinsic B cell abnormality.
Materials and Methods
Mice. MRL/Mp-+/+ (MRL/+),MRL/Mp-Ipr/Ipr(MRL/ lpr), C57BL/6ByJ (B6), B6 .C20 (B6-Igh'), C57BL/6-lpr/lpr (B6/lpr), C57BL/6-lpr/lpr-Igh'/Igh' (B6/lpr-Igh'), and (MRL/Ipr x B6/lpr)Fl were maintained in ourbreeding facility. The MRL/ lpr, MRL/+, B6, and B6/lpr strains were originally obtained from The Jackson Laboratory (Bar Harbor, ME), and the B6 .C20 was obtained from Gayle Bosma (Institute for Cancer Research, Philadelphia, PA). The B6/lpr-Igh' strain was developed in our laboratory by crossing B6 .C20 and B6/lpr. Homozygosity for Igh' and lpr was tested at the F2 generation, and the strain was established from a single breeding pair. B6/lpr-Igh' characteristically develop significant lymphadenopathy, splenomegaly, and autoantibodies to chromatin and IgG by 5 mo-of-age.
Production of Double Chimeras. 1 wk before cell transfer, 2-3-mo-old mice were bled and transferred to autoclaved cages in an isolation cubicle and provided with neomycin (0 .2% w/v)-treated water. On the day of bone marrow transfer, the mice received 900 rad of y-radiation in a Gammacell 40 '3'Cs apparatus (Atomic Energy of Canada, Ltd., Ottawa, Canada). Bone marrow cells (BMCs) were prepared from the femurs and tibias of age-and sexmatched congenic mice . After extensive washing in RPMI 1640 buffered with 15 mM HEPES and supplemented with penicillin and streptomycin, BMCs were resuspended at 20 x 106/ml and treated with saturating concentrations of monoclonal rat antiThy 1. Immunization of Chimeras with Thnitrophenyl--Human Serum Albumin (TNPHSA~Human serum albumin was trinitrophenylated using 2,4,6 trinitrobenzenesulfonic acid (Eastman Kodak Co., Rochester, NY). Each mouse was injected subcutaneously with 0.1 mg TNP-HSA in CFA (0 .5 ml), followed, at 20-d intervals, by two i.p. booster injections of 0.05 mg TNP-HSA in PBS. Mice were bled midway between injections and 10 d after the second boost.
Enzyme-linked Immunosorbent Assay (ELISA) Total Serum IgM and IgM". This assay is a modification of a previously described protocol (26) . Polyvinylchloride microtiter plates (Dynatech Laboratories, Inc., Alexandria, VA) were coated with 100 pl/well of Bet 2, a non-allotype-specific rat anti-mouse IgM mAb (27) , at 1.5 itg/ml in borate buffered saline (BBS). The plates were then washed in BBS and incubated with 200 Ed/well of coating buffer (BBS, 0.5% BSA, 0.4% Tween 80, and 0.1% NaN3) for at least 1 h. After aspiration, serum samples or standard positive sera diluted 1:2000 to 1:5000 in coating buffer were added and allowed to bind overnight in the cold . Standard curves for calibration of the assay consisted of two-fold serial dilutions of TEPC 183 (mouse IgM' ; Organon Teknika, Durham, NC) and CBPC 112 (mouse IgMb; [26] ). The assay was developed with biotinylated HB100 (rat IgG1 anti-mouse IgM' ; [27] ) and AF6-78 . 25 .2 (mouse IgG1 anti-IgMb; [28] ). In addition, standard curves were compared to each other by development with biotinylated Bet 2. Plates were then incubated with avidin-alkaline phosphatase and developed with paranitrophenyl phosphate (PNP; Sigma Chemical Co., St . Louis, MO) at 1 mg/ml in 0.01 M diethanolamine (DEA), pH 9.8 . The plates were read on an automated ELISA reader (Emax; Molecular Devices Corporation, Menlo Park, CA) at timed intervals. OD results were converted to ug/ml based on the concentration of TEPC 183.
Total Serum IgG2a°and IgG2ak Microtiter plates were coated with 100 Al/well affinity-purified goat anti-mouse Fab' (3 wg/ml) in BBS as first step . Sera were diluted at 1:100,000 or 1:1,000,000 in coating buffer, and standard curves consisted of serial dilutions of HB63 (IgG2a'; [26] ) and CBPC 101 (IgG2ab; [26] ). The plates were washed, and previously standardized affinity-purified rabbit anti-mouse IgG2a' or IgG2ab were added to replicate plates . Standard curves were also developed with affinity-purified biotinylated goat anti-mouse pFc' as an allotype nonspecific reagent. The plates were then treated as above, and results are expressed as pg/ml based on the concentration of HB63.
Total IgGl' and IgGl k This assay was performed as an allotype-specific competitive inhibition ELISA. Microtiter plates were coated with 20-9 .10 (mAb anti-mouse IgGl'; [29] ) or 412-49 .7 .20 (mAb anti-mouse IgGlb; a gift of Dr. Fred Finkelman, Uniformed Services University of the Health Sciences, Bethesda, MD) at 3 Ftg/ml (100 wl/well) in BBS. After washing, plates were incubated with 200 jA1/well of coating buffer. To inactivate IgM rheumatoid factor, serum samples were reduced by being diluted 1:250 into 0.005 M dithiothreitol in BBS (BBS-DTT). Two-fold serial dilutions of HB57 (mouse IgG1'; [26] ) and MOPC 245 (mouse IgGlb; [26] ) were also prepared in BBS-DTT After reduction for 1 h at room temperature, samples were alkylated with an equal volume of0 .011 M iodoacetamide in BBS. After 15 min, each sample was divided into two equal aliquots, and an equal volume of a 2 ug/ml solution of either HB57-alkaline phosphatase (HB57-AP) or MOPC 245-alkaline phosphatase (MOPC 245AP) was added . Those samples containing HB57-AP were added to plates coated with 20-9-10 and those with MOPC 245-AP were added to plates coated with 412-49 .7 .20. After 2 h at 4°C, the plates were washed and PNP substrate in DEA was added. Plates were read at intervals as above . Standards and control sera of one allotype could not inhibit the other in this assay.
Allotype-specific IgM and IgG2a Anti-Chromatin. These assays paralleled those described above for allotype-specific total IgM and IgG2a, except that chromatin, purified from chicken erythrocyte nuclei (30) , was used as the first step (3 Rg/ml protein; 100 ul/well), and samples were diluted 1:500. Total immunoglobulin isotype levels and anti-chromatin were generally determined in the same assay. Results are reported based on the concentration of TEPC 183 (for IgM anti-chromatin) or HB63 (for IgG2a anti-chromatin) .
Allotype-specific IgM Anti-IgGl' and -IgG2b6 Rheumatoid Factor. Myeloma proteins HB57 (mouse IgGl') and BPC4 (mouse IgG2bb) were absorbed with a Bet 2-Sepharose 4B gel to reduce background, and used to coat microtiter plates at a concentration of 3 ug/ml . After washing, plates were incubated with coating buffer, followed by 1 :500 dilutions of sera . Standard curves were developed using serial dilutions of serum from reference B6/lpr and B6/lpr-Igh' mice . Following overnight incubation, previously standardized dilutions of biotinylated F(ab') Z fragments of HB100 (anti-IgM') or AF6-78. 25 .2 (anti-IgMb) were added to replicate plates. In addition, serial dilutions of reference sera were also developed with biotinylated F(ab')2 fragments of Bet 2 to allow standardization to each other. The rest of the assay was handled as above, except for data analysis, where results are reported in equivalent dilution factors (EDF) . This is defined by the formula: EDF = (Dilution of standard reference sera which gives the equivalent OD of the test serum) x 106 (30).
Immunofluorescence. Allotype-specific two-color IgD and IgM immunofluorescence was routinely performed on PBMCs and selectively on splenocytes to assess chimerism. Approximately 200 pl of tail vein blood was collected into heparinized tubes, and mononuclear cells were isolated using Lympholyte M (Cedarlane, Homby, Ontario) density gradients. White cells were collected into buffered HBSS, supplemented with 3% FCS and 0 .1% NaN3. For IgD staining, saturating amounts of AF3-33 .3 .2 (IgG2a anti-IgDb ; [28] ) and biotinylated Hb'/1 (IgG2b anti-IgD' ; a generous gift of Dr. F. Finkelman) were added for 30 min at 4°C. The second step consisted of incubation with saturating amounts of fluoresceinated goat anti-mouse IgG2a (Southern Biotechnology Associates, Birmingham, AL) and PE-coupled avidin (Southern Biotechnology Associates) . The cells were washed three times in PBS and fixed with an equal volume of 2% paraformaldehyde in PBS . The IgM protocol followed that for IgD except that AF6-78 .25 .2 (IgG1 antiIgMb) was used as the first step, followed, after washing, by saturating amounts of fluoresceinated goat anti-mouse IgG1 (Southern Biotechnology Associates) . After more washing, more AF6-78 .25 .2 was added to saturate any unoccupied second-step binding sites . Biotinylated DSl (IgG1 anti-IgM'; [31] ) was added and followed, after washing, by PE-coupled avidin . In all cases, B6.C20, B6, and (B6.C20 x B6)Fl PBLs were prepared concurrently as controls. Analysis was performed on an Epics V flow cytometer (Coulter Electronics Inc., Hialeah, FL) with size gating on the lymphocyte population . Data were plotted on a three-decade logarithmic scale. At least 5,000 events were collected for each sample.
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Results
Initial (32, 33) . Consistent with our earlier results (17), the peripheral blood of mice from each group showed substantial numbers of cells from each donor type, although in Groups II and III, the IF cells predominated over the +/+ cells by an average ratio of 2 :1. 6-7 mo after transfer, the mice were sacrificed. Groups II-V had marked lymphadenopathy, and the expanded populations mainly expressed the aberrant DNT phenotype, Thy 1+ CD4 -CD8 -9F3+, typical of 1pr T cells . Groups II and III had a marked predominance of cells of the Ipr vs +/+ phenotype in the lymph nodes (80% vs 5%), but the thymus was equally reconstituted, again in agreement with earlier results . Examination of splenic B cells showed I-Ab to IAk ratios similar to those seen for H-2 expression in the peripheral blood (data not shown) .
Serum total IgM and IgG2a levels were determined by allotype-specific ELISA . Group II and III showed strong skewing towards the allotype of the 1pr donor. All mice were also tested for IgM rheumatoid factor, IgG2a anti-ssDNA, and IgG2a anti-chromatin in allotype-specific ELISAs. In Groups II and III, autoantibodies were mainly of the 1pr donor allotype (data not shown) . These data suggested two alternative hypotheses : (a) The production of autoantibodies in 
Serum Ig in Double Chimeric Mice Came from both Bone
Marrow Donors. IgM, IgG2a, and IgG1 of the a and b allotypes were detected in all double chimeric mice tested at 4 mo after reconstitution (Table 1) . In Groups II and III, the lpr donor allotype (a and b, respectively) dominated in all cases, particularly for IgG2a and IgG1 in Group III . In Groups I and IV neither allotype was consistently favored, although the b allotype was increased in the IgGl and IgG2a isotypes in Group I.
Autoantibodies Were Derivedfrom lpr Donor Marrow. IgM and IgG2a anti-chromatin autoantibody levels were determined by allotype-specific ELISAs 4 mo after reconstitution (Table  1) . Strikingly, in Groups II and III, IgM and IgG2a antichromatin autoantibodies were wholly of the lpr donor allotype. The double lpr chimeras in Group IV had substantial amounts of anti-chromatin of both allotypes, while Group I showed only very low levels ofb allotype autoantibody (probably due to recipient marrow recovery; see Discussion) .
Rheumatoid factors reactive with murine IgGla and IgG2bb were also assayed (Table 1) . Again, autoantibodies in mice of Groups II and III were derived entirely from the lpr donor B cells. Trace levels of rheumatoid factor were present in Group I mice, while Group IV mice had RF of both allotypes .
4 B Cells in Ipr Mice
Results Were Similar with B6/lpr--Igha Hosts. Parallel experiments were performed with B6/lpr-Igh' recipients, and data from one of two similar experiments are summarized in the bottom halfof Table 1 . Immunofluorescence of PBMCs again showed mixed chimerism, although Groups I and IV showed some excess of B cells of the a allotype. Serum total IgM, IgG2a, and IgG1 were generally balanced in Groups I and IV (except IgG2a in Group I), while these isotypes were mostly skewed toward the lpr donor allotype in Groups II and III . As in the B6/lpr-recipient chimeras, autoantibodies in Groups II and III were entirely of the lpr donor allotype, with the exception of a single Group III mouse, in which there was some IgG2a' anti-chromatin in the presence of a larger amount of IgG2ab anti-chromatin . ('"g/ml) (!Ug/ml) (/Ug/ml) (fUg/ml) (ng/ml) B6/lpr recipientss I 17(3)1 21 (5) 28(6) (7) 18(6) 32(5) 3(1) (4) 6(2) 22(5) 7(1) ticularly as detected by anti-IgM, although the normal B cell predominance persisted in most cases. At 4 mo, four representative mice were sacrificed, and their spleens were examined by immunofluorescence (Fig. 1) . The relative proportions of cells expressing the a and b allotypes were comparable to that seen in peripheral blood and still favored the normal a allotype. Table 2 lists the serological data for individual mice 3-4 mo after reconstitution . In spite of the cellular bias towards the normal +/+ B cells, total serum IgM was relatively evenly balanced at this time. In contrast, serum total IgG2a and IgG1 were strongly biased towards the b allotype of the lpr donor. Autoantibodies were detected in most dice and were derived solely from the Ipr donor.
In Presence of lpr, Normal B Cells Showed Little Response to Exogenous Antigen . To determine whether,the +/+ B cells present in +/+-Ipr double chimeras were potentially functional, approximately 7 mo after reconstitution, mice from each of the four groups shown in the top half of Table 1 were immunized with TNRHSA. Group I mice showed low preimmunization levels of antiTNP antibody and a strong IgG2a response of both allotypes (Fig. 2) . In contrast, lpr B cells in Groups II, III and IV showed high preimmunization titers of antiTNP, but had little additional response to immuniza-144 5
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tion . +/+ B cells in Groups II and III had low preimmunization titers, but produced only a blunted response to antigen . IgM antiTNP had a decreased but parallel response (data not shown) . This experiment was repeated at an earlier time following reconstitution (4 mo) using some of the B6/lpr recipients given an excess of +/+ marrow, again with similar results (data not shown) .
Discussion
The present results indicate that the production of antibodies in the lpr model of SLE requires expression of the lpr gene in B cells. Preliminary experiments were performed by transferring combinations of MRL and B6 bone marrow into irradiated (MRL/Ipr x B6/lpr)F1 hosts. We confirmed our earlier results demonstrating an intrinsic T cell abnormality (17). Surprisingly, autoantibodies appeared to be made preferentially by cells from the lpr donor. Although this result suggested that an Ipr-specific abnormality had to be expressed in the B cells that produced autoantibodies, we could not exclude the possibility that abnormal lpr T cells preferentially interacted with the syngeneic (i&, H-2 compatible) Ipr B cells. We therefore performed additional experiments with chimeras constructed using Igh-allotype congenic strains of B6 mice. To exclude the possibility of systematic assay errors and to assess better the potential differences in autoantibody production afforded by different Igh genes, both B6/lpr and B6/lpr-Igh' hosts were tested . An additional possible confounding factor was host bone marrow recovery, despite lethal irradiation (34) :-In this regard, for B6/lpr hosts, data from Group III, a mixture of B6.C20 and B6/lpr donor marrow, allowed the clearest assessment of the contribution of B cells derived from infused normal marrow, since, in these cases, host bone marrow recovery could only add to the antibody bearing the 1pr donor allotype. Likewise, for B6/IprIgh' hosts, Group II, was the most critical . In both of these groups, serum total IgM and IgG antibody were mainly of the 1pr donor allotype, yet B cells and immunoglobulin from the +/+ donor were clearly present . Nevertheless, autoantibodies derived from normal donor cells were never seen, even though anti-chromatin and rheumatoid factor of the Ipr allotype were usually present . Recipient bone marrow recovery probably accounted for the increased amounts of b and a allotype IgG in B6/lpr and B6/lpr-Igh', respectively, in Group I of Igh' recipient which made appreciable levels of a allotype IgG2a anti-chromatin . Finally, the crossover design of our experiments also excluded the possibility that the preferential use of the b allotype for autoantibody production, which we have previously shown (35) , could obscure the interpretation of our results. The ability to construct bona,fide +/+-1pr double chimeras was critical to our approach. It has been reported that reconstitution of IF mice with a mixture of 1pr and +/+ marrow results in complete takeover by 1pr marrow within 1 mo (34) , although experience in our laboratory has been different (17). In the current work, recipients of a 1:1 ratio of +/+ :lpr showed a predominance of the Ipr-derived B cells in the peripheral blood; however, +/+ B cells were always present in si numbers (Table 1) . In those double chimeras reconstituted with excess normal bone marrow, the number of +/+ phenotype B cells usually exceeded that of 1pr origin, in both the peripheral blood and the spleen (Table 2 ) . In these same animals, serum IgM was nearly balanced, while serum IgG2a and IgG1 was dominated by the allotype derived from the lpr donor. As in the donor-balanced chimeras, autoantibodies of the IgM and IgG2a isotypes were entirely of 1pr origin .
Other work has suggested a role for cells not of bone marrow origin in the development of 1pr lymphadenopathy (36) (37) (38) . When lpr bone marrow is introduced into a lethally irradiated congenic +/+ mouse, a curious wasting syndrome ensues, leading to lymphoid depletion and early mortality (39, 40) . If, however, an lpr lymph node is also transplanted, these mice will develop adenopathy in that transplanted node (38) , suggesting that nonhemopoietic cells may be necessary for full expression of the T cell defect . Perkins et al . (25) have demonstrated that neonatal +/+ mice given lpr bone marrow produce preferentially Ipr-allotype IgG2a and IgG2a anti-ssDNA . These results indicated an intrinsic lpr B cell defect, as shown in our current studies. Our present data extend these observations to show that a complete lpr environment, including the expanded population of lpr T cells, is still not sufficient to stimulate normal B lymphocytes to secrete autoantibodies, thus indicating that the lpr B cell is an absolute requirement for autoantibody production in lpr mice. An additional finding in the current study was that normal lymphoid cells appeared to be immunosuppressed in an lpr environment . This result parallels the impaired responses lpr mice are known to have to exogenous antigens (41, 42) . In double chimeric mice immunized with the T cell dependent antigen, TNP-HSA, the normal B cells responded poorly in 1447 Sobel et al .
the presence of lpr donor marrow (Groups II and III ; Fig.  2 ). This immunosuppression was not due to the non-bonemarrow-derived lpr host environment, since lpr mice reconstituted with normal marrows (Group I) had a good IgG2a response to TNP. Therefore, we assume that either the lpr T cells or the lpr B cells exerted a strong downregulatory effect in vivo. We are currently investigating the mechanism of this suppression with further double chimera experiments .
The observed results cannot easily be explained by transfer of lpr B cells already committed to autoantibody production . Autoantibodies did not become evident until at least 2 mo after transfer. In addition, examination by immunofluorescence of bone marrow cells from lpr and normal mice failed to show any appreciable staining for mouse K light chains (data not shown) . Furthermore, allophenic mice, made by the fusion of 1pr and normal embryos, also showed autoantibodies only of the lpr phenotype (T Katagiri, S . Azuma, Y Toyoda, S. Mori, K. Kano, P.L. Cohen, and R.A . Eisenberg, manuscript in preparation) . The present study thus suggests that either the lpr cells were specifically driven to IgG and autoantibody production or that the +/+ cells were inhibited from doing so. In any case, the presence of the lpr gene was essential for the production of autoantibodies by the B cells.
The finding that lpr B cells are intrinsically abnormal raises questions as to the relative role of T cell and B cell defects in the lpr model of autoimmune disease. Although T cells are clearly required for autoantibody production in lpr mice,
